Assessment of cardiovascular risk in type 1 diabetes mellitus taking into account various markers of kidney damage
- Authors: Goldschmid A.E1, Karamullina R.A1, Chechikova E.I1, Amosova M.V1, Poluboyarinova I.V1, Fadeev V.V1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 12, No 4 (2020)
- Pages: 51-55
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273320
- DOI: https://doi.org/10.18565/nephrology.2020.4.51-55
- ID: 273320
Cite item
Abstract
Full Text
About the authors
A. E Goldschmid
Sechenov First Moscow State Medical University (Sechenov University)
Email: goldsmid93@gmail.com
Endocrinologist Moscow, Russia
R. A Karamullina
Sechenov First Moscow State Medical University (Sechenov University)Postgraduate student Moscow, Russia
E. I Chechikova
Sechenov First Moscow State Medical University (Sechenov University)Medical Resident Moscow, Russia
M. V Amosova
Sechenov First Moscow State Medical University (Sechenov University)Cand. Sci. (Med.), Teaching Assistant at the Department of Endocrinology №1 Moscow, Russia
I. V Poluboyarinova
Sechenov First Moscow State Medical University (Sechenov University)Cand. Sci. (Med.), Teaching Assistant at the Department of Endocrinology №1 Moscow, Russia
V. V Fadeev
Sechenov First Moscow State Medical University (Sechenov University)Corresponding member of RAS, Dr. Sci. (Med.), Professor, Director of the Clinic, Head of the Department of Endocrinology № 1 Moscow, Russia
References
- Sharma H., Lencioni M., Narendran P. Cardiovascular disease in type 1 diabetes. Cardiovasc. Endocrinol. Metab. 2019;8(1):28-34. Doi:10.1097/ XCE.0000000000000167.
- Dedov I.I., Shestakova M.V., Vikulova O.K. Epidemiology of diabetes mellitus in Russian Federation: Clinical and statistical report according to the federal diabetes registry. Diab. Mellit. 2017;20(1):13-41. doi: 10.14341/DM8664.
- Morimoto A., Onda Y., Nishimura R., et al. Cause-specific mortality trends in a nationwide population-based cohort of childhood-onset type 1 diabetes in Japan during 35 years of follow-up: the DERI Mortality Study. Diabetol. 2013;56(10):2171-5. doi: 10.1007/s00125-013-3001-2.
- Libby P., Nathan D.M., Abraham K., et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111(25):3489-93. Doi: 10.1161/ CIRCULATIONAHA.104.529651.
- UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetol. 1991;34(12):877-90.
- Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., Colhoun H.M. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diab. Care. 2006;29(4):798-804. Doi: 10.2337/ diacare.29.04.06.dc05-1433.
- Mattock M.B., Morrish N.J., Viberti G., Keen H., Fitzgerald A.P., Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41(6):736-41. Doi: 10.2337/ diab.41.6.736.
- Wu T., McGrath K.C.Y, Death A.K. Cardiovascular disease in diabetic nephropathy patients: cell adhesion molecules as potential markers? Vasc. Health. Risk Manag. 2005;1(4):309-16. doi: 10.2147/vhrm.2005.1.4.309.
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. (London, England). 1998;352(9131):837-53.
- de Zeeuw D., Remuzzi G., Parving H-H., et al. Albuminuria, a therapeutic targetfor cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110(8):921-7. doi: 10.1161/01.CIR.0000139860.33974.28.
- Anavekar N.S., Gans D.J., Berl T., et al. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int. 2004;92( Suppl.):S50-5. Doi: 10.1111/j. 1523-1755.2004.09213.x.
- Cederholm J., Eeg-Olofsson K., Eliasson B., Zethelius B., Gudbjornsdottir S. A new modelfor 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR). Diab. Med. 2011;28(10):1213- 20. doi: 10.1111/j.1464-5491.2011.03342.x.